BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32004646)

  • 1. A prospective cohort study of condensed low-dose total skin electron beam therapy for mycosis fungoides: Reduction of disease burden and improvement in quality of life.
    Song A; Gochoco A; Zhan T; Sahu J; Alpdogan O; Porcu P; Nikbakht N; Shi W
    J Am Acad Dermatol; 2020 Jul; 83(1):78-85. PubMed ID: 32004646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a pooled analysis from 3 phase-II clinical trials.
    Hoppe RT; Harrison C; Tavallaee M; Bashey S; Sundram U; Li S; Million L; Dabaja B; Gangar P; Duvic M; Kim YH
    J Am Acad Dermatol; 2015 Feb; 72(2):286-92. PubMed ID: 25476993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides).
    Quirós PA; Jones GW; Kacinski BM; Braverman IM; Heald PW; Edelson RL; Wilson LD
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):1027-35. PubMed ID: 9276369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose total skin electron beam therapy: Quality of life improvement and clinical impact of maintenance and adjuvant treatment in patients with mycosis fungoides or Sezary syndrome.
    Elsayad K; Kroeger K; Greve B; Moustakis C; Assaf C; Stadler R; Lenz G; Weishaupt C; Eich HT
    Strahlenther Onkol; 2020 Jan; 196(1):77-84. PubMed ID: 31591658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose (10-Gy) total skin electron beam therapy for cutaneous T-cell lymphoma: an open clinical study and pooled data analysis.
    Kamstrup MR; Gniadecki R; Iversen L; Skov L; Petersen PM; Loft A; Specht L
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):138-43. PubMed ID: 25863761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose total skin electron beam therapy as a debulking agent for cutaneous T-cell lymphoma: an open-label prospective phase II study.
    Kamstrup MR; Lindahl LM; Gniadecki R; Iversen L; Skov L; Petersen PM; Loft A; Specht L
    Br J Dermatol; 2012 Feb; 166(2):399-404. PubMed ID: 21967035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute toxicity and risk of infection during total skin electron beam therapy for mycosis fungoides.
    Lloyd S; Chen Z; Foss FM; Girardi M; Wilson LD
    J Am Acad Dermatol; 2013 Oct; 69(4):537-43. PubMed ID: 23849563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and sub-acute toxicity profile of ultra-hypofractionated low-dose total skin electron beam with two 4 Gy fractions for cutaneous T cell lymphoma.
    Rolf D; Elsayad K; Eich HT
    J Cancer Res Clin Oncol; 2021 Jun; 147(6):1757-1761. PubMed ID: 33219856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-institutional Investigation: Circulating CD4:CD8 ratio is a prognosticator of response to total skin electron beam radiation in mycosis fungoides.
    An Y; Jiang W; Andraos TY; Reddy JP; Yehia ZA; Lloyd S; Duvic M; D'Souza NM; Milgrom SA; Pinnix CC; Oki Y; Smith GL; Wilson LD; Dabaja BS
    Radiother Oncol; 2019 Feb; 131():88-92. PubMed ID: 30773193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valchlor maintenance therapy for patients with mycosis fungoides who received low dose total skin electron beam treatment.
    Jennings T; Duffy R; Gochoco A; Knoblauch K; Shi W; Alpdogan SO; Porcu P; Werner-Wasik M; Sahu J
    Chin Clin Oncol; 2019 Feb; 8(1):13. PubMed ID: 30525753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultimate results of radiation therapy for T1-T2 mycosis fungoides (including reirradiation).
    Ysebaert L; Truc G; Dalac S; Lambert D; Petrella T; Barillot I; Naudy S; Horiot JC; Maingon P
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1128-34. PubMed ID: 15001254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total Skin Electron Beam Therapy in the Treatment of Mycosis Fungoides: A Review of Conventional and Low-Dose Regimens.
    Chowdhary M; Chhabra AM; Kharod S; Marwaha G
    Clin Lymphoma Myeloma Leuk; 2016 Dec; 16(12):662-671. PubMed ID: 27692530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy.
    Wilson LD; Licata AL; Braverman IM; Edelson RL; Heald PW; Feldman AM; Kacinski BM
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):987-95. PubMed ID: 7607973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliative total skin electron beam therapy (TSEBT) for advanced cutaneous T-cell lymphoma.
    Funk A; Hensley F; Krempien R; Neuhof D; Van Kampen M; Treiber M; Roeder F; Timke C; Herfarth K; Helmbold P; Debus J; Bischof M
    Eur J Dermatol; 2008; 18(3):308-12. PubMed ID: 18474461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long term results of total skin electron beam therapy (TSEBT) in the treatment of mycosis fungoides].
    Hagedorn M; Hasche E; Kober B; Sander CA
    Hautarzt; 2003 Mar; 54(3):256-64. PubMed ID: 12634995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient perspectives regarding the value of total skin electron beam therapy for cutaneous T-cell lymphoma/mycosis fungoides: a pilot study.
    Yu JB; Khan AM; Jones GW; Reavely MM; Wilson LD
    Am J Clin Oncol; 2009 Apr; 32(2):142-4. PubMed ID: 19307950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrahypofractionated Low-Dose Total Skin Electron Beam in Advanced-Stage Mycosis Fungoides and Sézary Syndrome.
    Elsayad K; Weishaupt C; Moustakis C; Danzer MF; Müller EC; Rolf D; Stranzenbach R; Livingstone E; Booken N; Stadler R; Eich HT
    Int J Radiat Oncol Biol Phys; 2023 Sep; 117(1):164-170. PubMed ID: 36893819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides.
    Chinn DM; Chow S; Kim YH; Hoppe RT
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):951-8. PubMed ID: 10192339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in total skin electron beam therapy modalities for mycosis fungoides: A single-centre study.
    Canu D; Pham-Ledard A; Ouhabrache N; Beylot-Barry M
    Ann Dermatol Venereol; 2022 Sep; 149(3):180-184. PubMed ID: 35595588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total skin electron beam therapy in mycosis fungoides-a shift towards lower dose?
    Chowdhary M; Song A; Zaorsky NG; Shi W
    Chin Clin Oncol; 2019 Feb; 8(1):9. PubMed ID: 30525748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.